Coloplast has received FDA approval for its Titan Prime inflatable penile prosthesis (IPP), a next-generation device designed to help men with severe erectile dysfunction. The device mimics a natural erection using a durable Bioflex polymer, offering improved comfort and reliability compared to silicone-based competitors. Titan Prime will be available in the US starting late 2026 through a phased rollout to urologists and healthcare systems. This approval marks a significant advancement in prosthetic urology, providing a long-term treatment option for millions of men struggling with erectile dysfunction.
Hydaway Digital Corp. has appointed Angelo Valentini, a cybersecurity industry veteran and current Head of Channel Sales at Check Point Software Technologies, as a strategic advisor. Valentini will support the advancement of Hydaway's RealityChek AI ...
The global wound irrigation systems market, valued at $307.87 million in 2025, is projected to reach $430.05 million by 2035 with a CAGR of 3.55%. Growth is fueled by increasing chronic wound cases, more surgeries, and rising diabetes and obesity rat...
ScottsMiracle-Gro reaffirmed its fiscal 2026 guidance, expecting low single-digit sales growth and a gross margin of at least 32%. The company reported a 1% increase in year-to-date branded consumer sales and has locked 90% of its commodities costs, ...
Ulta Beauty reported first-quarter fiscal 2026 earnings of $7.74 per share, surpassing analyst estimates of $6.86, with revenue rising 11.1% year-over-year to $3.16 billion. The company saw growth across fragrance, haircare, makeup, and skincare cate...
Vertiv Holdings Co announced a quarterly cash dividend of $0.0625 per share for its Class A common stock. The dividend will be paid on June 25, 2026, to shareholders recorded by June 15, 2026. Vertiv is a global leader in critical digital infrastruct...
